- PDB-7kyz: Solution structures of full-length K-RAS bound to GDP -
+
Open data
ID or keywords:
Loading...
-
Basic information
Entry
Database: PDB / ID: 7kyz
Title
Solution structures of full-length K-RAS bound to GDP
Components
Isoform 2B of GTPase KRas
Keywords
CELL CYCLE
Function / homology
Function and homology information
forebrain astrocyte development / negative regulation of epithelial cell differentiation / regulation of synaptic transmission, GABAergic / type I pneumocyte differentiation / epithelial tube branching involved in lung morphogenesis / Rac protein signal transduction / skeletal muscle cell differentiation / positive regulation of Rac protein signal transduction / Signaling by RAS GAP mutants / Signaling by RAS GTPase mutants ...forebrain astrocyte development / negative regulation of epithelial cell differentiation / regulation of synaptic transmission, GABAergic / type I pneumocyte differentiation / epithelial tube branching involved in lung morphogenesis / Rac protein signal transduction / skeletal muscle cell differentiation / positive regulation of Rac protein signal transduction / Signaling by RAS GAP mutants / Signaling by RAS GTPase mutants / Activation of RAS in B cells / RAS signaling downstream of NF1 loss-of-function variants / RUNX3 regulates p14-ARF / SOS-mediated signalling / Activated NTRK3 signals through RAS / Activated NTRK2 signals through RAS / SHC1 events in ERBB4 signaling / Signalling to RAS / SHC-related events triggered by IGF1R / Activated NTRK2 signals through FRS2 and FRS3 / glial cell proliferation / Estrogen-stimulated signaling through PRKCZ / SHC-mediated cascade:FGFR3 / MET activates RAS signaling / Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants / Signaling by PDGFRA extracellular domain mutants / SHC-mediated cascade:FGFR2 / PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases / SHC-mediated cascade:FGFR4 / Signaling by FGFR4 in disease / Erythropoietin activates RAS / SHC-mediated cascade:FGFR1 / protein-membrane adaptor activity / FRS-mediated FGFR3 signaling / Signaling by CSF3 (G-CSF) / Signaling by FLT3 ITD and TKD mutants / positive regulation of glial cell proliferation / FRS-mediated FGFR2 signaling / FRS-mediated FGFR4 signaling / Signaling by FGFR3 in disease / homeostasis of number of cells within a tissue / p38MAPK events / Tie2 Signaling / FRS-mediated FGFR1 signaling / Signaling by FGFR2 in disease / striated muscle cell differentiation / GRB2 events in EGFR signaling / SHC1 events in EGFR signaling / EGFR Transactivation by Gastrin / Signaling by FLT3 fusion proteins / FLT3 Signaling / Signaling by FGFR1 in disease / GRB2 events in ERBB2 signaling / CD209 (DC-SIGN) signaling / Ras activation upon Ca2+ influx through NMDA receptor / NCAM signaling for neurite out-growth / SHC1 events in ERBB2 signaling / Downstream signal transduction / Constitutive Signaling by Overexpressed ERBB2 / Insulin receptor signalling cascade / Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants / small monomeric GTPase / VEGFR2 mediated cell proliferation / FCERI mediated MAPK activation / Signaling by ERBB2 TMD/JMD mutants / RAF activation / Constitutive Signaling by EGFRvIII / regulation of long-term neuronal synaptic plasticity / Signaling by high-kinase activity BRAF mutants / Signaling by ERBB2 ECD mutants / MAP2K and MAPK activation / visual learning / Signaling by ERBB2 KD Mutants / Signaling by SCF-KIT / G protein activity / cytoplasmic side of plasma membrane / Regulation of RAS by GAPs / Signaling by CSF1 (M-CSF) in myeloid cells / RAS processing / Negative regulation of MAPK pathway / Signaling by RAF1 mutants / Signaling by moderate kinase activity BRAF mutants / Paradoxical activation of RAF signaling by kinase inactive BRAF / Signaling downstream of RAS mutants / GDP binding / MAPK cascade / Signaling by BRAF and RAF1 fusions / DAP12 signaling / Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants / Ca2+ pathway / gene expression / actin cytoskeleton organization / RAF/MAP kinase cascade / neuron apoptotic process / negative regulation of neuron apoptotic process / Ras protein signal transduction / mitochondrial outer membrane / positive regulation of protein phosphorylation / Golgi membrane / focal adhesion Similarity search - Function
Small GTPase, Ras-type / small GTPase Ras family profile. / Ran (Ras-related nuclear proteins) /TC4 subfamily of small GTPases / Rho (Ras homology) subfamily of Ras-like small GTPases / Ras subfamily of RAS small GTPases / Small GTPase / Ras family / Rab subfamily of small GTPases / Small GTP-binding protein domain / P-loop containing nucleoside triphosphate hydrolase Similarity search - Domain/homology
Mass: 21459.605 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: KRAS, KRAS2, RASK2 / Production host: Escherichia coli (E. coli) / References: UniProt: P01116, small monomeric GTPase
-
Experimental details
-
Experiment
Experiment
Method: SOLUTION NMR
NMR experiment
Conditions-ID
Experiment-ID
Solution-ID
Sample state
Spectrometer-ID
Type
1
1
2
isotropic
3
1D1H
1
2
2
isotropic
3
2D 1H-15N HSQC
1
3
3
isotropic
1
2D 1H-13C HSQC aliphatic
1
4
3
isotropic
1
2D 1H-13C HSQC aromatic
1
5
2
isotropic
3
3D 1H-15N TOCSY
1
15
3
isotropic
3
3D HN(CA)CB
1
14
3
isotropic
3
3DCBCA(CO)NH
1
13
3
isotropic
3
3D HNCA
1
12
3
isotropic
3
3DHN(CO)CA
1
11
3
isotropic
3
3DC(CO)NH
1
10
3
isotropic
3
3D HNCO
1
9
3
isotropic
2
3D 1H-15N NOESY
1
8
3
isotropic
2
2D 1H-13C HSQC aromatic
1
7
3
isotropic
2
3D 1H-13C NOESY aliphatic
1
6
3
isotropic
2
2D 1H-15N HSQC
-
Sample preparation
Details
Type
Solution-ID
Contents
Details
Label
Solvent system
solution
2
0.7-0.9 mM [U-100% 15N] GTPase KRas, 20 mM [U-2H] MES, 100 mM potassium chloride, 50 mM sodium chloride, 2 mM MgCl2, 1 mM [U-2H] TCEP, 7 mM [U-2H] D2O, 0.05 % sodium azide, 90% H2O/10% D2O
0.7-0.9 mM sample was treated with 2.5% of DMSO to match equal composition of a separate sample that was treated with small-molecule cysteine inhibitor in DMSO. Sample was subsequently purified using Liquid Chromatography (FPLC) system.
15N_sample
90% H2O/10% D2O
solution
3
0.7-0.9 mM [U-13C; U-15N] GTPase KRas, 20 mM [U-2H] MES, 100 mM potassium chloride, 50 mM sodium chloride, 2 mM MgCl2, 1 mM [U-2H] TCEP, 7 mM [U-2H] D2O, 0.05 % sodium azide, 90% H2O/10% D2O
0.7-0.9 mM sample was treated with 2.5% of DMSO to match equal composition of a separate sample that was treated with small-molecule cysteine inhibitor in DMSO. Sample was subsequently purified using Liquid Chromatography (FPLC) system.
13C15N_sample
90% H2O/10% D2O
Sample
Conc. (mg/ml)
Units
Component
Isotopic labeling
Conc. range (mg/ml)
Solution-ID
20mM
MES
[U-2H]
2
100mM
potassiumchloride
naturalabundance
2
50mM
sodiumchloride
naturalabundance
2
2mM
MgCl2
naturalabundance
2
1mM
TCEP
[U-2H]
2
7mM
D2O
[U-2H]
2
0.05 %
sodiumazide
naturalabundance
2
20mM
MES
[U-2H]
3
100mM
potassiumchloride
naturalabundance
3
50mM
sodiumchloride
naturalabundance
3
2mM
MgCl2
naturalabundance
3
1mM
TCEP
[U-2H]
3
7mM
D2O
[U-2H]
3
0.05 %
sodiumazide
naturalabundance
3
mM
GTPaseKRas
[U-13C; U-15N]
0.7-0.9
3
mM
GTPaseKRas
[U-100% 15N]
0.7-0.9
2
Sample conditions
Details: Samples were freshly prepared in NMR buffer pH 6.5. NMR Data was collected with 320 uL sample volume at 298K. Sample apparently held the concentration during the week long data acquisition ...Details: Samples were freshly prepared in NMR buffer pH 6.5. NMR Data was collected with 320 uL sample volume at 298K. Sample apparently held the concentration during the week long data acquisition with one sample. Two 13C15N labeled NMR samples and one 15N labeled NMR sample was used for all data collection. Ionic strength: 0.15 M / Label: conditions_1 / pH: 6.5 / Pressure: 1 atm / Temperature: 298 K
-
NMR measurement
NMR spectrometer
Type
Manufacturer
Model
Field strength (MHz)
Spectrometer-ID
Details
Bruker AVANCE III HD
Bruker
AVANCEIIIHD
800
1
TS3.5.6
Bruker AVANCE
Bruker
AVANCE
900
2
TS2.1.6
Bruker AVANCE III
Bruker
AVANCEIII
700
3
TS3.5.6
-
Processing
NMR software
Name
Version
Developer
Classification
TopSpin
4
BrukerBiospin
collection
NMRPipe
10.9
Delaglio, Grzesiek, Vuister, Zhu, PfeiferandBax
processing
CcpNmr Analysis
2.4
CCPN
chemicalshiftassignment
PONDEROSA
LeeW, PetitCM, CornilescuG, StarkJL, MarkleyJL.
peakpicking
CYANA
3.98.13
Guntert, MumenthalerandWuthrich
refinement
PONDEROSA
LeeW, PetitCM, CornilescuG, StarkJL, MarkleyJL.
refinement
CYANA
3.98.13
Guntert, MumenthalerandWuthrich
structurecalculation
Refinement
Method: torsion angle dynamics / Software ordinal: 4 Details: structures are based on 2140 distance restraints, 138 hydrogen bond restraints as deduced from secondary structure and the tertiary fold detremined using refinement process, and 238 dihedral angle restraints
NMR representative
Selection criteria: target function
NMR ensemble
Conformer selection criteria: target function / Conformers calculated total number: 100 / Conformers submitted total number: 20
+
About Yorodumi
-
News
-
Feb 9, 2022. New format data for meta-information of EMDB entries
New format data for meta-information of EMDB entries
Version 3 of the EMDB header file is now the official format.
The previous official version 1.9 will be removed from the archive.
In the structure databanks used in Yorodumi, some data are registered as the other names, "COVID-19 virus" and "2019-nCoV". Here are the details of the virus and the list of structure data.
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)
EMDB accession codes are about to change! (news from PDBe EMDB page)
The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
The EM Navigator/Yorodumi systems omit the EMD- prefix.
Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator
Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.
Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi